On the contrary, early lung adenocarcinoma manifesting as GGN showed lower density, slower growth, less expression of glucose transporter-1 (GLUT-1), less uptake of FDG, and lower SUVmax (28, 29). The gene discussed is SLC2A1; the disease is lung adenocarcinoma.